nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A5—dilated cardiomyopathy	0.567	1	CbGaD
L-Carnitine—SLC22A5—Furosemide—dilated cardiomyopathy	0.116	0.55	CbGbCtD
L-Carnitine—SLC22A8—Furosemide—dilated cardiomyopathy	0.0945	0.45	CbGbCtD
L-Carnitine—SLC22A16—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.0159	0.166	CbGpPWpGaD
L-Carnitine—SLC22A16—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.0108	0.113	CbGpPWpGaD
L-Carnitine—SLC22A4—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.00587	0.0614	CbGpPWpGaD
L-Carnitine—CROT—myocardium—dilated cardiomyopathy	0.00492	0.0797	CbGeAlD
L-Carnitine—SLC25A20—cardiac ventricle—dilated cardiomyopathy	0.00455	0.0737	CbGeAlD
L-Carnitine—Acetylcarnitine—SLC22A5—dilated cardiomyopathy	0.00452	0.771	CrCbGaD
L-Carnitine—CRAT—cardiac ventricle—dilated cardiomyopathy	0.00442	0.0715	CbGeAlD
L-Carnitine—SLC25A20—myocardium—dilated cardiomyopathy	0.00428	0.0693	CbGeAlD
L-Carnitine—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.00426	0.0711	CcSEcCtD
L-Carnitine—CRAT—myocardium—dilated cardiomyopathy	0.00415	0.0673	CbGeAlD
L-Carnitine—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00398	0.0416	CbGpPWpGaD
L-Carnitine—SLC25A29—heart—dilated cardiomyopathy	0.00375	0.0607	CbGeAlD
L-Carnitine—CROT—heart—dilated cardiomyopathy	0.00344	0.0556	CbGeAlD
L-Carnitine—CPT2—cardiac ventricle—dilated cardiomyopathy	0.0034	0.055	CbGeAlD
L-Carnitine—CPT2—myocardium—dilated cardiomyopathy	0.0032	0.0517	CbGeAlD
L-Carnitine—SLC25A20—heart—dilated cardiomyopathy	0.00299	0.0484	CbGeAlD
L-Carnitine—CRAT—heart—dilated cardiomyopathy	0.0029	0.047	CbGeAlD
L-Carnitine—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00271	0.0283	CbGpPWpGaD
L-Carnitine—SLC25A20—cardiac atrium—dilated cardiomyopathy	0.00256	0.0414	CbGeAlD
L-Carnitine—CRAT—cardiac atrium—dilated cardiomyopathy	0.00248	0.0402	CbGeAlD
L-Carnitine—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00246	0.0411	CcSEcCtD
L-Carnitine—CPT1A—heart—dilated cardiomyopathy	0.00235	0.0381	CbGeAlD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.00233	0.0243	CbGpPWpGaD
L-Carnitine—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.0023	0.0384	CcSEcCtD
L-Carnitine—CPT2—heart—dilated cardiomyopathy	0.00223	0.0361	CbGeAlD
L-Carnitine—CPT2—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.00222	0.0232	CbGpPWpGaD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.00218	0.0228	CbGpPWpGaD
L-Carnitine—SLC22A16—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00216	0.0225	CbGpPWpGaD
L-Carnitine—CPT2—cardiac atrium—dilated cardiomyopathy	0.00191	0.0309	CbGeAlD
L-Carnitine—Fluid overload—Lisinopril—dilated cardiomyopathy	0.00164	0.0274	CcSEcCtD
L-Carnitine—Gastritis—Spironolactone—dilated cardiomyopathy	0.00161	0.0269	CcSEcCtD
L-Carnitine—XDH—Purine catabolism—GPX1—dilated cardiomyopathy	0.00161	0.0168	CbGpPWpGaD
L-Carnitine—MPO—myocardium—dilated cardiomyopathy	0.00158	0.0257	CbGeAlD
L-Carnitine—CPT1A—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.00154	0.0161	CbGpPWpGaD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.00151	0.0158	CbGpPWpGaD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.0015	0.0157	CbGpPWpGaD
L-Carnitine—Renal failure—Spironolactone—dilated cardiomyopathy	0.00138	0.023	CcSEcCtD
L-Carnitine—Choline—SLC22A5—dilated cardiomyopathy	0.00135	0.23	CrCbGaD
L-Carnitine—CES1—heart—dilated cardiomyopathy	0.00132	0.0215	CbGeAlD
L-Carnitine—CPT1A—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00126	0.0131	CbGpPWpGaD
L-Carnitine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00125	0.0209	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00116	0.0122	CbGpPWpGaD
L-Carnitine—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00115	0.0193	CcSEcCtD
L-Carnitine—MPO—heart—dilated cardiomyopathy	0.00111	0.0179	CbGeAlD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00109	0.0114	CbGpPWpGaD
L-Carnitine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00105	0.0176	CcSEcCtD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.00104	0.0109	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00102	0.0107	CbGpPWpGaD
L-Carnitine—SLC22A5—cardiac ventricle—dilated cardiomyopathy	0.00102	0.0165	CbGeAlD
L-Carnitine—SLC22A4—heart—dilated cardiomyopathy	0.00101	0.0164	CbGeAlD
L-Carnitine—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.001	0.0168	CcSEcCtD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000979	0.0102	CbGpPWpGaD
L-Carnitine—SLC22A5—myocardium—dilated cardiomyopathy	0.000958	0.0155	CbGeAlD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000926	0.00969	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000926	0.00969	CbGpPWpGaD
L-Carnitine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000895	0.015	CcSEcCtD
L-Carnitine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000872	0.0146	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000871	0.00911	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000871	0.00911	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00083	0.00868	CbGpPWpGaD
L-Carnitine—Injury—Lisinopril—dilated cardiomyopathy	0.000807	0.0135	CcSEcCtD
L-Carnitine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000798	0.00834	CbGpPWpGaD
L-Carnitine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000782	0.0131	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000771	0.0129	CcSEcCtD
L-Carnitine—Renal failure—Furosemide—dilated cardiomyopathy	0.000749	0.0125	CcSEcCtD
L-Carnitine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000706	0.0118	CcSEcCtD
L-Carnitine—XDH—Oxidative Stress—SOD2—dilated cardiomyopathy	0.000699	0.00731	CbGpPWpGaD
L-Carnitine—SLC22A5—heart—dilated cardiomyopathy	0.000668	0.0108	CbGeAlD
L-Carnitine—XDH—Oxidative Stress—GPX1—dilated cardiomyopathy	0.000667	0.00697	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000658	0.011	CcSEcCtD
L-Carnitine—Gastritis—Lisinopril—dilated cardiomyopathy	0.000656	0.011	CcSEcCtD
L-Carnitine—Influenza—Lisinopril—dilated cardiomyopathy	0.000641	0.0107	CcSEcCtD
L-Carnitine—Eye disorder—Furosemide—dilated cardiomyopathy	0.000639	0.0107	CcSEcCtD
L-Carnitine—Pruritus—Spironolactone—dilated cardiomyopathy	0.000632	0.0106	CcSEcCtD
L-Carnitine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00062	0.0104	CcSEcCtD
L-Carnitine—XDH—Purine metabolism—GPX1—dilated cardiomyopathy	0.000618	0.00646	CbGpPWpGaD
L-Carnitine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000616	0.0103	CcSEcCtD
L-Carnitine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000611	0.0102	CcSEcCtD
L-Carnitine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000611	0.0102	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000597	0.00624	CbGpPWpGaD
L-Carnitine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00059	0.00986	CcSEcCtD
L-Carnitine—Weight increased—Lisinopril—dilated cardiomyopathy	0.000583	0.00975	CcSEcCtD
L-Carnitine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000583	0.00974	CcSEcCtD
L-Carnitine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00058	0.00969	CcSEcCtD
L-Carnitine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000572	0.00956	CcSEcCtD
L-Carnitine—SLC22A5—cardiac atrium—dilated cardiomyopathy	0.000572	0.00926	CbGeAlD
L-Carnitine—Depression—Lisinopril—dilated cardiomyopathy	0.00057	0.00952	CcSEcCtD
L-Carnitine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000568	0.00949	CcSEcCtD
L-Carnitine—Rash—Spironolactone—dilated cardiomyopathy	0.000563	0.00941	CcSEcCtD
L-Carnitine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000562	0.0094	CcSEcCtD
L-Carnitine—Renal failure—Lisinopril—dilated cardiomyopathy	0.000562	0.00939	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000561	0.00587	CbGpPWpGaD
L-Carnitine—Headache—Spironolactone—dilated cardiomyopathy	0.000559	0.00935	CcSEcCtD
L-Carnitine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000555	0.00928	CcSEcCtD
L-Carnitine—Anaemia—Furosemide—dilated cardiomyopathy	0.00055	0.00919	CcSEcCtD
L-Carnitine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000542	0.00567	CbGpPWpGaD
L-Carnitine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000536	0.00896	CcSEcCtD
L-Carnitine—Vertigo—Furosemide—dilated cardiomyopathy	0.000535	0.00893	CcSEcCtD
L-Carnitine—Nausea—Spironolactone—dilated cardiomyopathy	0.00053	0.00886	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—RPS6KB1—dilated cardiomyopathy	0.000525	0.00549	CbGpPWpGaD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000523	0.00547	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.000523	0.00547	CbGpPWpGaD
L-Carnitine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000514	0.00859	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000512	0.00535	CbGpPWpGaD
L-Carnitine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000509	0.00851	CcSEcCtD
L-Carnitine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000505	0.00844	CcSEcCtD
L-Carnitine—CPT2—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.0005	0.00523	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000498	0.0052	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000498	0.0052	CbGpPWpGaD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000489	0.00512	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—ANKRD1—dilated cardiomyopathy	0.000485	0.00507	CbGpPWpGaD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000471	0.00493	CbGpPWpGaD
L-Carnitine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000465	0.00778	CcSEcCtD
L-Carnitine—Anorexia—Furosemide—dilated cardiomyopathy	0.000463	0.00774	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000463	0.00484	CbGpPWpGaD
L-Carnitine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000458	0.00766	CcSEcCtD
L-Carnitine—CROT—Metabolism—TAZ—dilated cardiomyopathy	0.000456	0.00477	CbGpPWpGaD
L-Carnitine—Hypotension—Furosemide—dilated cardiomyopathy	0.000454	0.00758	CcSEcCtD
L-Carnitine—CPT2—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.00045	0.00471	CbGpPWpGaD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000441	0.00461	CbGpPWpGaD
L-Carnitine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000437	0.00731	CcSEcCtD
L-Carnitine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000436	0.00729	CcSEcCtD
L-Carnitine—Back pain—Lisinopril—dilated cardiomyopathy	0.000432	0.00722	CcSEcCtD
L-Carnitine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000429	0.00717	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000425	0.00445	CbGpPWpGaD
L-Carnitine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000422	0.00706	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000419	0.00701	CcSEcCtD
L-Carnitine—Pain—Furosemide—dilated cardiomyopathy	0.000415	0.00694	CcSEcCtD
L-Carnitine—Constipation—Furosemide—dilated cardiomyopathy	0.000415	0.00694	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000414	0.00433	CbGpPWpGaD
L-Carnitine—Anaemia—Lisinopril—dilated cardiomyopathy	0.000413	0.0069	CcSEcCtD
L-Carnitine—CROT—Metabolism—SDHA—dilated cardiomyopathy	0.000413	0.00431	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ANKRD1—dilated cardiomyopathy	0.000413	0.00431	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ANKRD1—dilated cardiomyopathy	0.000413	0.00431	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000406	0.00424	CbGpPWpGaD
L-Carnitine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000401	0.0067	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000397	0.00664	CcSEcCtD
L-Carnitine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000395	0.00659	CcSEcCtD
L-Carnitine—Cough—Lisinopril—dilated cardiomyopathy	0.00039	0.00651	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000389	0.00407	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—TAZ—dilated cardiomyopathy	0.000388	0.00406	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—TAZ—dilated cardiomyopathy	0.000388	0.00406	CbGpPWpGaD
L-Carnitine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000384	0.00642	CcSEcCtD
L-Carnitine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000384	0.00642	CcSEcCtD
L-Carnitine—Myalgia—Lisinopril—dilated cardiomyopathy	0.00038	0.00635	CcSEcCtD
L-Carnitine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00038	0.00635	CcSEcCtD
L-Carnitine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000379	0.00633	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000362	0.00379	CbGpPWpGaD
L-Carnitine—Infection—Lisinopril—dilated cardiomyopathy	0.000362	0.00605	CcSEcCtD
L-Carnitine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000358	0.00598	CcSEcCtD
L-Carnitine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000356	0.00594	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—SDHA—dilated cardiomyopathy	0.000351	0.00367	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—SDHA—dilated cardiomyopathy	0.000351	0.00367	CbGpPWpGaD
L-Carnitine—Asthenia—Furosemide—dilated cardiomyopathy	0.000348	0.00582	CcSEcCtD
L-Carnitine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000347	0.0058	CcSEcCtD
L-Carnitine—CPT1A—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000347	0.00362	CbGpPWpGaD
L-Carnitine—Pruritus—Furosemide—dilated cardiomyopathy	0.000344	0.00574	CcSEcCtD
L-Carnitine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000341	0.00569	CcSEcCtD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000339	0.00355	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000338	0.00353	CbGpPWpGaD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000337	0.00353	CbGpPWpGaD
L-Carnitine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000332	0.00555	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000332	0.00555	CcSEcCtD
L-Carnitine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00033	0.00551	CcSEcCtD
L-Carnitine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000327	0.00547	CcSEcCtD
L-Carnitine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000325	0.00543	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000324	0.00339	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000322	0.00337	CbGpPWpGaD
L-Carnitine—Dizziness—Furosemide—dilated cardiomyopathy	0.000321	0.00537	CcSEcCtD
L-Carnitine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000321	0.00536	CcSEcCtD
L-Carnitine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000317	0.00529	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000315	0.00526	CcSEcCtD
L-Carnitine—CPT1A—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000312	0.00326	CbGpPWpGaD
L-Carnitine—Constipation—Lisinopril—dilated cardiomyopathy	0.000312	0.00521	CcSEcCtD
L-Carnitine—Pain—Lisinopril—dilated cardiomyopathy	0.000312	0.00521	CcSEcCtD
L-Carnitine—XDH—Nucleotide metabolism—GPX1—dilated cardiomyopathy	0.00031	0.00325	CbGpPWpGaD
L-Carnitine—Vomiting—Furosemide—dilated cardiomyopathy	0.000309	0.00516	CcSEcCtD
L-Carnitine—Rash—Furosemide—dilated cardiomyopathy	0.000306	0.00512	CcSEcCtD
L-Carnitine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000306	0.00511	CcSEcCtD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000305	0.00319	CbGpPWpGaD
L-Carnitine—Headache—Furosemide—dilated cardiomyopathy	0.000304	0.00508	CcSEcCtD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000304	0.00318	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000298	0.00498	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000295	0.00309	CbGpPWpGaD
L-Carnitine—Nausea—Furosemide—dilated cardiomyopathy	0.000288	0.00482	CcSEcCtD
L-Carnitine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000288	0.00481	CcSEcCtD
L-Carnitine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000288	0.00481	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000282	0.00295	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000281	0.00294	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000268	0.00449	CcSEcCtD
L-Carnitine—CPT2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000266	0.00278	CbGpPWpGaD
L-Carnitine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000261	0.00437	CcSEcCtD
L-Carnitine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000258	0.00431	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—TNF—dilated cardiomyopathy	0.000256	0.00268	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000252	0.00263	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—TAZ—dilated cardiomyopathy	0.00025	0.00261	CbGpPWpGaD
L-Carnitine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000249	0.00417	CcSEcCtD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000246	0.00258	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000245	0.00256	CbGpPWpGaD
L-Carnitine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000241	0.00403	CcSEcCtD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000234	0.00244	CbGpPWpGaD
L-Carnitine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000232	0.00387	CcSEcCtD
L-Carnitine—Rash—Lisinopril—dilated cardiomyopathy	0.00023	0.00384	CcSEcCtD
L-Carnitine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00023	0.00384	CcSEcCtD
L-Carnitine—Headache—Lisinopril—dilated cardiomyopathy	0.000228	0.00381	CcSEcCtD
L-Carnitine—CPT2—Metabolism—SDHA—dilated cardiomyopathy	0.000226	0.00236	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000221	0.00231	CbGpPWpGaD
L-Carnitine—Nausea—Lisinopril—dilated cardiomyopathy	0.000216	0.00362	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000214	0.00224	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000214	0.00224	CbGpPWpGaD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.00021	0.0022	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000208	0.00218	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000208	0.00218	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000206	0.00215	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000198	0.00207	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000189	0.00198	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000188	0.00196	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000188	0.00196	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000187	0.00196	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ANKRD1—dilated cardiomyopathy	0.000184	0.00193	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000184	0.00193	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000184	0.00193	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—TAZ—dilated cardiomyopathy	0.000173	0.00181	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000171	0.00179	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TNF—dilated cardiomyopathy	0.000161	0.00169	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SDHA—dilated cardiomyopathy	0.000157	0.00164	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000144	0.00151	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000142	0.00149	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000138	0.00145	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000138	0.00144	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000136	0.00142	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000134	0.0014	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000129	0.00135	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000129	0.00135	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000128	0.00134	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000125	0.00131	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000125	0.00131	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ANKRD1—dilated cardiomyopathy	0.000122	0.00128	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000121	0.00126	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000116	0.00122	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TAZ—dilated cardiomyopathy	0.000115	0.0012	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GPX1—dilated cardiomyopathy	0.000112	0.00117	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000112	0.00117	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CD36—dilated cardiomyopathy	0.000109	0.00114	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000107	0.00112	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SDHA—dilated cardiomyopathy	0.000104	0.00109	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000101	0.00106	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AGT—dilated cardiomyopathy	9.83e-05	0.00103	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.77e-05	0.00102	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.56e-05	0.000999	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GPX1—dilated cardiomyopathy	9.53e-05	0.000997	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GPX1—dilated cardiomyopathy	9.53e-05	0.000997	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.51e-05	0.000994	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.51e-05	0.000994	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.31e-05	0.000973	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CD36—dilated cardiomyopathy	9.28e-05	0.000971	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CD36—dilated cardiomyopathy	9.28e-05	0.000971	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.84e-05	0.000924	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.38e-05	0.000876	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AGT—dilated cardiomyopathy	8.36e-05	0.000874	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AGT—dilated cardiomyopathy	8.36e-05	0.000874	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	6.42e-05	0.000672	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GPX1—dilated cardiomyopathy	6.14e-05	0.000642	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	6.04e-05	0.000632	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CD36—dilated cardiomyopathy	5.98e-05	0.000625	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	5.46e-05	0.000571	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AGT—dilated cardiomyopathy	5.38e-05	0.000563	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GPX1—dilated cardiomyopathy	4.26e-05	0.000445	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CD36—dilated cardiomyopathy	4.14e-05	0.000433	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.74e-05	0.000391	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AGT—dilated cardiomyopathy	3.73e-05	0.00039	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.33e-05	0.000348	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.24e-05	0.000339	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.92e-05	0.000306	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GPX1—dilated cardiomyopathy	2.82e-05	0.000295	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.81e-05	0.000294	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CD36—dilated cardiomyopathy	2.75e-05	0.000287	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.54e-05	0.000266	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AGT—dilated cardiomyopathy	2.47e-05	0.000259	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.93e-05	0.000202	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	1.48e-05	0.000155	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	1.45e-05	0.000151	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	1.3e-05	0.000136	CbGpPWpGaD
